Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: study Dr. Shravani Dali7 July 2022 2:30 PM GMTDurvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer, according to a recent study published in the NEJM Evidence Patients...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 8:30 AM GMTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Sortilin may hold key to counter pancreatic cancer more effectively Hina Zahid22 Aug 2020 5:08 AM GMTPhiladelphia - Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel...
